https://scholars.lib.ntu.edu.tw/handle/123456789/594886
Title: | Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study | Authors: | Zucali P.A. CHIA-CHI LIN Carthon B.C. Bauer T.M. Tucci M. Italiano A. Iacovelli R. Su W.-C. Massard C. Saleh M. Daniele G. Greystoke A. Gutierrez M. Pant S. YING-CHUN SHEN Perrino M. Meng R. Abbadessa G. Lee H. Dong Y. Chiron M. Wang R. Loumagne L. L?pine L. De Bono J. |
Issue Date: | 2022 | Publisher: | BMJ Publishing Group | Journal Volume: | 10 | Journal Issue: | 1 | Source: | Journal for ImmunoTherapy of Cancer | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123747016&doi=10.1136%2fjitc-2021-003697&partnerID=40&md5=a7fcbe94e10fac056b7ff30c633645d3 https://scholars.lib.ntu.edu.tw/handle/123456789/594886 |
ISSN: | 2051-1426 | DOI: | 10.1136/jitc-2021-003697 |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.